ClinicalTrials.Veeva

Menu

Recurrent Extrahepatic Bile Duct Stones as a Late Complication of ERCP in Patients With Coexisting Intra- and Extrahepatic Bile Duct Stones

A

Air Force Military Medical University of People's Liberation Army

Status

Enrolling

Conditions

Intrahepatic Bile Duct Stone
Choledocholithiasis

Study type

Observational

Funder types

Other

Identifiers

NCT06041113
KY20232281-C-1

Details and patient eligibility

About

The management of coexisting intrahepatic bile duct (IBD) and extrahepatic bile duct (EBD) stones is complicated and requires a multidisciplinary approach. The long-term clinical outcomes of patients initially treated with endoscopic retrograde cholangiopancreatography (ERCP) EBD stone extraction remain unclear. Investigators conducted a retrospective study of patients with coexisting IBD and EBD to investigate the long-term impact of ERCP on the incidence of recurrent EBD stones and to identify risk factors of recurrence.

Enrollment

104 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • non-gastrointestinal tract reconstruction patients with coexisting IBD and EBD stones who underwent ERCP between July 2008 and December 2020 at Xijing Hospital in China

Exclusion criteria

  • patients with benign or malignant EBD strictures
  • sclerosing cholangitis
  • suspected choledochal cysts
  • liver cirrhosis
  • parasitic liver diseases
  • long-term biliary drainage with biliary stents or percutaneous tubes
  • without a definitive IBD stone or with a diagnosis of liver calcification as determined by imaging review
  • medical records or follow-up information was unavailable

Trial contacts and locations

1

Loading...

Central trial contact

Yanglin Pan, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems